Finland· FI-REL-REL52863
Ketorolac S.A.L.F.
A ketorolac product containing ketorolac trometamol, registered in Finland by SALF SpA Laboratorio Farmacologico. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ketorolac is registered in 9 of 19 countries.
Countries holding a registration under ATC M01AB15 (ketorolac), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Ketorolac · ATC M01AB15
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketorolac costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketorolac · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- US United States$0.49 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Ketorolac trometamol
- Manufacturer
- SALF SpA Laboratorio Farmacologico
- Country
- Finland (FI)
- ATC code
- M01AB15
- ATC class
- Ketorolac
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for ketorolac.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketorolac · interactions on record
378 records
- 69 severe
- 129 moderate
- 5 minor
- 94 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ketorolac in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayCaloketEQL Pharma AB
- SwedenCaloket 30 mg/ml Injektions-/infusionsvätska, lösningEQL Pharma AB
- United StatesAcularAllergan, Inc.
- United KingdomAcular 0.5% eye dropsSigma Pharmaceuticals Plc
- CanadaACULARABBVIE CORPORATION
- ItalyBENKETOLPHARMABER S.R.L.
- CzechiaKETOROLAC TROMETAMOL BROWN & BURKBrown & Burk IR Limited, Dublin
- SpainACULAR 5 mg/ml COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Acular, Ketorolac Micro Labs
- Belgium · Aculare, Taradyl
- Bulgaria · Кетоажур, Кеторолак Вижън
- Cyprus · Errkes
- Czechia · Ketorolac Trometamol Brown & Burk
- Germany · Ketorolac Micro Labs, Ketovision
- Denmark · Acular, Caloket
- Estonia · Ketorolac Baxter
- Spain · Acular, Ketorolaco Kabi
- France · Acular
- United Kingdom (Northern Ireland) · Acular, Ketorolac Trometamol Baxter Healthcare
- Greece · Acular, Errkes
- Ireland · Acular
- Iceland · Toradol
- Italy · Acular, Benketol
- Lithuania · Ketanov, Ketorolac Baxter
- Luxembourg · Aculare, Taradyl
- Latvia · Ketanov, Ketorolac Baxter
- Norway · Caloket, Ketorolac Trometamol S.A.L.F.
- Poland · Ketorolac Trometamol Brown & Burk
- Portugal · Acular, Cetorolac
- Romania · Ketanov, Ketorol
- Sweden · Caloket, Ketorolac S.A.L.F.
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6710ead-5975-4ff4-90b0-2de8345e7149 GET /v1/drugs/f6710ead-5975-4ff4-90b0-2de8345e7149?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "30",
"form": "injektioneste, liuos",
"route": "Laskimoon",
"ddd_unit": "mg",
"strength": "30 mg/ml",
"atc_label": "ketorolaakki",
"ma_number": "36099",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL52863",
"authorised_at": "2019-04-26"
}See everything about ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.